Small interfering RNA-induced CHFR silencing sensitizes oral squamous cell cancer cells to microtubule inhibitors

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cancer Biology & Therapy

• Publication date

  2005-05-25

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.4161/cbt.4.7.1896PMID 16123600
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chfr is required for tumor suppression and Aurora A regulation

  2005cited by this paper
• The CHFR mitotic checkpoint protein delays cell cycle progression by excluding Cyclin B1 from the nucleus

  2005cited by this paper
• Retracted: The evolution of predictive oncology and molecular‐based therapy for oral cancer prevention

  2005cited by this paper
• Multicenter phase I trial of induction chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinoma.

  2004cited by this paper
• Nuclear localization of cyclin B1 regulates DNA damage-induced apoptosis.

  2003cited by this paper
• Silencing of the Novel p53 Target Gene Snk/Plk2 Leads to Mitotic Catastrophe in Paclitaxel (Taxol)-Exposed Cells

  2003cited by this paper
• Epigenetic inactivation of CHFR and sensitivity to microtubule inhibitors in gastric cancer.

  2003cited by this paper
• Phosphorylation of serine 10 in histone H3, what for?

  2003cited by this paper
• Epigenetic inactivation of CHFR in human tumors

  2003cited by this paper
• Inactivating mutations targeting the chfr mitotic checkpoint gene in human lung cancer.

  2003cited by this paper
• Frequent hypermethylation of the 5' CpG island of the mitotic stress checkpoint gene Chfr in colorectal and non-small cell lung cancer.

  2003cited by this paper
• The Chfr mitotic checkpoint protein functions with Ubc13-Mms2 to form Lys63-linked polyubiquitin chains

  2003cited by this paper
• Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumors

  2003cited by this paper
• Paclitaxel increases p21 synthesis and accumulation of its AKT-phosphorylated form in the cytoplasm of cancer cells

  2003cited by this paper
• Cell-cycle dysregulation and anticancer therapy.

  2003cited by this paper
• Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers

  2002cited by this paper
• The checkpoint protein Chfr is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition

  2002cited by this paper
• Chfr regulates a mitotic stress pathway through its RING-finger domain with ubiquitin ligase activity.

  2002cited by this paper
• Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53

  2001cited by this paper
• Cancer Statistics, 2001

  2001cited by this paper
• Chfr defines a mitotic stress checkpoint that delays entry into metaphase

  2000cited by this paper
• The FHA domain, a phosphoamino acid binding domain involved in the DNA damage response pathway.

  2000cited by this paper
• The FHA domain is a modular phosphopeptide recognition motif.

  1999cited by this paper
• Correlations of bcl-2 and p53 expression with the clinicopathological features in tongue squamous cell carcinomas.

  1999cited by this paper
• Disruption of p53 in human cancer cells alters the responses to therapeutic agents.

  1999cited by this paper
• DNA rereplication in the presence of mitotic spindle inhibitors in human and mouse fibroblasts lacking either p53 or pRb function.

  1997cited by this paper
• Cancer statistics

  1989cited by this paper
• Interspecies spleen-myeloma hybrid producing monoclonal antibodies against mouse lymphocyte surface glycoprotein, T200

  1978cited by this paper

• CHFR expression and sensitivity of breast cancer cells to antimitotic agents in vitro and in the I-SPY trial

  2025cites this paper
• What is epigenetics?

  2022cites this paper
• CHFR and Paclitaxel Sensitivity of Ovarian Cancer

  2021cites this paper
• Five gene signatures were identified in the prediction of overall survival in resectable pancreatic cancer

  2020cites this paper
• CHFR Promoter Hypermethylation Is Associated with Gastric Cancer and Plays a Protective Role in Gastric Cancer Process

  2019cites this paper
• Association of CHFR Promoter Methylation with Treatment Outcomes of Irinotecan-Based Chemotherapy in Metastatic Colorectal Cancer

  2018cites this paper
• Upregulation of the checkpoint protein CHFR is associated with tumor suppression in pancreatic cancers

  2017cites this paper
• Methylation of CHFR sensitizes esophageal squamous cell cancer to docetaxel and paclitaxel

  2015cites this paper
• Rlim, an E3 ubiquitin ligase, influences the stability of Stathmin protein in human osteosarcoma cells.

  2014cites this paper
• CHFR silencing or microsatellite instability is associated with increased antitumor activity of docetaxel or gemcitabine in colorectal cancer

  2014cites this paper
• The role of Chfr and Ubc13 in mitosis.

  2013cites this paper
• Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine

  2013cites this paper
• CHFR Promoter Methylation Indicates Poor Prognosis in Stage II Microsatellite Stable Colorectal Cancer

  2013cites this paper
• CHFR Protein Expression Predicts Outcomes to Taxane-Based First Line Therapy in Metastatic NSCLC

  2013cites this paper
• (Epi-) genetic profiling of colorectal cancer : prognostic and biological relevance, with emphasis on tumor-hypoxia

  2012cites this paper
• Epigenetics and genetics in endometrial cancer: new carcinogenic mechanisms and relationship with clinical practice.

  2012cites this paper
• Expression level of the mitotic checkpoint protein and G2–M cell cycle regulators and prognosis in gastrointestinal stromal tumors in the stomach

  2012cites this paper
• DNA methylation biomarkers in cancer: progress towards clinical implementation

  2012cites this paper
• Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer

  2012cites this paper
• CHFR: a key checkpoint component implicated in a wide range of cancers

  2012cites this paper
• Aberrant DNA Methylation in Endometrial Cancer

  2012cites this paper
• RNA interference targeting CHFR enhances taxol chemosensitivity in endometrial cancer cells.

  2012cites this paper
• DNA Methylation in the Pathogenesis of Head and Neck Cancer

  2012cites this paper
• CHFR Protein Regulates Mitotic Checkpoint by Targeting PARP-1 Protein for Ubiquitination and Degradation*

  2012influential citation
• Regulation and Function of the Mitotic Checkpoint Protein CHFR.

  2011cites this paper
• CHFR Suppression by Hypermethylation Sensitizes Endometrial Cancer Cells to Paclitaxel

  2011cites this paper
• Epigenetic Aberrant Hypermethylation of DNA in Endometrial Cancer: Application as a Biomarker

  2011cites this paper
• Epigenetic drivers of genetic alterations.

  2010cites this paper
• Alternative efficacy-predicting markers for paclitaxel instead of CHFR in non-small-cell lung cancer

  2010cites this paper
• Connections between CHFR, the cell cycle, and chemosensitivity: Are they critical in cancer?

  2010cites this paper
• Genes that modulate the sensitivity for anti-microtubule drug-mediated chemotherapy.

  2010cites this paper
• Epigenetic signatures in cancer: Implications for the control of cancer in the clinic.

  2010cites this paper
• 12 – Contribución de la epigenética al manejo personalizado del cáncer

  2010cites this paper
• Cancer epigenomics: Implications of DNA methylation in personalized cancer therapy

  2009cites this paper
• CHFR, a potential tumor suppressor, downregulates interleukin-8 through the inhibition of NF-κB

  2009cites this paper
• Epigenetic DNA hypermethylation: clinical applications in endometrial cancer (Review).

  2009cites this paper
• SIRT2 downregulation confers resistance to microtubule inhibitors by prolonging chronic mitotic arrest

  2009cites this paper
• CHFR Expression in Breast Cancer Cells: Its Relevance to Tumorigenesis and Genomic Stability.

  2008influential citation
• CHFR as a Potential Anticancer Target

  2008cites this paper
• The Anti-Proliferative Effects of the CHFR Depend on the Forkhead Associated Domain, but not E3 Ligase Activity Mediated by Ring Finger Domain

  2008cites this paper
• Decreased Expression of the Early Mitotic Gene CHFR Contributes to the Acquisition of Breast Cancer Phenotypes

  2008cites this paper
• FHA-RING ubiquitin ligases in cell division cycle control

  2008cites this paper
• Loss of CHFR in human mammary epithelial cells causes genomic instability by disrupting the mitotic spindle assembly checkpoint.

  2008cites this paper
• DNA methylation and cancer pathways in gastrointestinal tumors.

  2008cites this paper
• The anti-proliferative effects of the CHFR depend on the forkhead associated domain, but not E3 ligase activity activity mediated by ring finger domain

  2008cites this paper
• Epigenetic inactivation of RASSF2 in oral squamous cell carcinoma

  2008cites this paper
• CHFR: A Novel Mitotic Checkpoint Protein and Regulator of Tumorigenesis.

  2008influential citation
• The Molecular Biology of Mammalian SIRT Proteins: SIRT2 Functions on Cell Cycle Regulation

  2007cites this paper
• Altered expression of the early mitotic checkpoint protein, CHFR, in breast cancers: implications for tumor suppression.

  2007cites this paper
• Age-related genetic abnormalities: the Achilles' heel for customizing therapy in elderly lung cancer patients.

  2007cites this paper
• Epigenetic inactivation of SFRP genes in oral squamous cell carcinoma.

  1992cites this paper